Daniel G Welch - Net Worth and Insider Trading
Daniel G Welch Net Worth
The estimated net worth of Daniel G Welch is at least $4 Million dollars as of 2024-04-28. Daniel G Welch is the Director of Seagen Inc and owns about 17,519 shares of Seagen Inc (SGEN) stock worth over $4 Million. Daniel G Welch is also the Director of Intercept Pharmaceuticals Inc and owns about 3,108 shares of Intercept Pharmaceuticals Inc (ICPT) stock worth over $59,052. Details can be seen in Daniel G Welch's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the assumption that Daniel G Welch has not made any transactions after 2023-08-28 and currently still holds the listed stock(s).
Transaction Summary of Daniel G Welch
Daniel G Welch Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Daniel G Welch owns 7 companies in total, including Ultragenyx Pharmaceutical Inc (RARE) , Intercept Pharmaceuticals Inc (ICPT) , and Seagen Inc (SGEN) among others .
Click here to see the complete history of Daniel G Welch’s form 4 insider trades.
Insider Ownership Summary of Daniel G Welch
Ticker | Comapny | Transaction Date | Type of Owner |
---|---|---|---|
RARE | Ultragenyx Pharmaceutical Inc | 2015-04-08 | director |
ICPT | Intercept Pharmaceuticals Inc | 2020-05-28 | director |
SGEN | Seagen Inc | 2023-08-28 | director |
AVXS | AveXis Inc | 2018-05-15 | director |
CORI | Corium International Inc | 2014-04-02 | director |
NUVB | Nuvation Bio Inc | 2021-02-10 | director |
GPCR | Structure Therapeutics Inc | 2023-02-02 | director |
Daniel G Welch Latest Holdings Summary
Daniel G Welch currently owns a total of 2 stocks. Among these stocks, Daniel G Welch owns 17,519 shares of Seagen Inc (SGEN) as of August 28, 2023, with a value of $4 Million and a weighting of 98.55%. Daniel G Welch also owns 3,108 shares of Intercept Pharmaceuticals Inc (ICPT) as of July 31, 2017, with a value of $59,052 and a weighting of 1.45%.
Latest Holdings of Daniel G Welch
Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
---|---|---|---|---|---|
SGEN | Seagen Inc | 2023-08-28 | 17,519 | 228.74 | 4,007,296 |
ICPT | Intercept Pharmaceuticals Inc | 2017-07-31 | 3,108 | 19.00 | 59,052 |
Holding Weightings of Daniel G Welch
Daniel G Welch Form 4 Trading Tracker
According to the SEC Form 4 filings, Daniel G Welch has made a total of 8 transactions in Seagen Inc (SGEN) over the past 5 years, including 0 buys and 8 sells. The most-recent trade in Seagen Inc is the sale of 4,925 shares on August 28, 2023, which brought Daniel G Welch around $1 Million.
According to the SEC Form 4 filings, Daniel G Welch has made a total of 0 transactions in Intercept Pharmaceuticals Inc (ICPT) over the past 5 years. The most-recent trade in Intercept Pharmaceuticals Inc is the sale of 602 shares on July 31, 2017, which brought Daniel G Welch around $74,606.
Insider Trading History of Daniel G Welch
- 1
Daniel G Welch Trading Performance
Daniel G Welch Ownership Network
Ownership Network List of Daniel G Welch
Ownership Network Relation of Daniel G Welch
Daniel G Welch Owned Company Details
What does Ultragenyx Pharmaceutical Inc do?
Who are the key executives at Ultragenyx Pharmaceutical Inc?
Daniel G Welch is the director of Ultragenyx Pharmaceutical Inc. Other key executives at Ultragenyx Pharmaceutical Inc include EVP and Chief Medical Officer Eric Crombez , CBO & Senior Vice President Thomas Richard Kassberg , and EVP and General Counsel Karah Herdman Parschauer .
Ultragenyx Pharmaceutical Inc (RARE) Insider Trades Summary
Over the past 18 months, Daniel G Welch made no insider transaction in Ultragenyx Pharmaceutical Inc (RARE). Other recent insider transactions involving Ultragenyx Pharmaceutical Inc (RARE) include a net sale of 5,605 shares made by Theodore Alan Huizenga , a net sale of 127,435 shares made by Emil D Kakkis , and a net sale of 54,366 shares made by Thomas Richard Kassberg .
In summary, during the past 3 months, insiders sold 69,133 shares of Ultragenyx Pharmaceutical Inc (RARE) in total and bought 0 shares, with a net sale of 69,133 shares. During the past 18 months, 243,293 shares of Ultragenyx Pharmaceutical Inc (RARE) were sold and 0 shares were bought by its insiders, resulting in a net sale of 243,293 shares.
Ultragenyx Pharmaceutical Inc (RARE)'s detailed insider trading history can be found in Insider Trading Tracker table.
Ultragenyx Pharmaceutical Inc Insider Transactions
Daniel G Welch Mailing Address
Above is the net worth, insider trading, and ownership report for Daniel G Welch. You might contact Daniel G Welch via mailing address: 4611 University Dr, 4 University Place, Durham Nc 27707.